Indian Journal of Medical Microbiology IAMM  | About us |  Subscription |  e-Alerts  | Feedback |  Login   
  Print this page Email this page   Small font sizeDefault font sizeIncrease font size
 Home | Ahead of Print | Current Issue | Archives | Search | Instructions  
Users Online: 4224 Official Publication of Indian Association of Medical Microbiologists 
  ~   Site Statistics 
  ~   Addresses 
  ~   Search 
  ~   My Preferences 
  ~   Online Submission 

 


This article has been cited by
1Prediction of Sustained Virological Response to Combination Therapy with Pegylated Interferon Alfa and Ribavirin in Patients with Genotype 3 Chronic Hepatitis C
S. K. Tohra,S. Taneja,S. Ghosh,B. K. Sharma,A. Duseja,R. K. Dhiman,A. Das,Y. K. Chawla
Digestive Diseases and Sciences.2011;56(8)2449
[DOI]
2IL28B rs12980275 variant as a predictor of sustained virologic response to pegylated-interferon and ribavirin in chronic hepatitis C patients: A systematic review and meta-analysis
Hao Zheng,Man Li,Bing Chi,Xiao-xue Wu,Jia Wang,Dian-Wu Liu
Clinics and Research in Hepatology and Gastroenterology.2015;39(5)576
[DOI]
3Back from the Future: Treating Hepatitis C Virus with Conventional Interferon
Pankaj Puri,Vivek A Saraswat
Journal of Clinical and Experimental Hepatology.2012;2(1)3
[DOI]
4Indian National Association for Study of the Liver (INASL) Guidance for Antiviral Therapy Against HCV Infection: Update 2016
Pankaj Puri,Vivek A. Saraswat,Radha K. Dhiman,Anil C. Anand,Subrat K. Acharya,Shivaram P. Singh,Yogesh K. Chawla,Deepak N. Amarapurkar,Ajay Kumar,Anil Arora,Vinod K. Dixit,Abraham Koshy,Ajit Sood,Ajay Duseja,Dharmesh Kapoor,Kaushal Madan,Anshu Srivastava,Ashish Kumar,Manav Wadhawan,Amit Goel,Abhai Verma,Abhai Shalimar,Gaurav Pandey,Rohan Malik,Swastik Agrawal
Journal of Clinical and Experimental Hepatology.2016;6(2)119
[DOI]
5Indian National Association for Study of the Liver (INASL) Guidance for Antiviral Therapy Against HCV Infection in 2015
Pankaj Puri,Anil C. Anand,Vivek A. Saraswat,Subrat K. Acharya,Radha K. Dhiman,Shiv K. Sarin,Shivaram P. Singh,Yogesh K. Chawla,Rakesh Aggarwal,Deepak Amarapurkar,Anil Arora,Vinod K. Dixit,Ajit Sood,Samir Shah,Ajay Duseja,Dharmesh Kapoor,Dharmesh Shalimar,Kaushal Madan,Gaurav Pande,Aabha Nagral,Premashis Kar,Abraham Koshy,Amarender S. Puri,C.E. Eapen,Sandeep Thareja
Journal of Clinical and Experimental Hepatology.2015;5(3)221
[DOI]
6Consensus Statement of HCV TaskForce of the Indian National Association for Study of the Liver (INASL). PartII: INASL Recommendations for Management of HCV in India
Pankaj Puri,Anil C. Anand,Vivek A. Saraswat,Subrat K. Acharya,Shiv K. Sarin,Radha K. Dhiman,Rakesh Aggarwal,Shivaram P. Singh,Deepak Amarapurkar,Anil Arora,Mohinish Chhabra,Kamal Chetri,Gourdas Choudhuri,Vinod K. Dixit,Ajay Duseja,Ajay K. Jain,Dharmesh Kapoor,Premashis Kar,Abraham Koshy,Ashish Kumar,Kaushal Madan,Sri P. Misra,Mohan V.G. Prasad,Aabha Nagral,Amarendra S. Puri,R. Jeyamani,Sanjiv Saigal,Samir Shah,Praveen K. Sharma,Ajit Sood,Sandeep Thareja,Manav Wadhawan
Journal of Clinical and Experimental Hepatology.2014;4(2)117
[DOI]
7Chronic hepatitisC treatment outcomes in low- and middle-income countries: a systematic review and meta-analysis
Nathan Ford,Catherine Kirby,Kasha Singh,Edward J Mills,Graham Cooke,Adeeba Kamarulzaman,Philipp duCros
Bulletin of the World Health Organization.2012;90(7)540
[DOI]

2004 - Indian Journal of Medical Microbiology
Published by Wolters Kluwer - Medknow

Online since April 2001, new site since 1st August '04